Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
HEART FAILURE / RESEARCH LETTER
Baseline characteristics of 1,422 patients with heart failure from the HEart failuRe ObsErvational Study of the Polish Cardiac Society (HEROES)
1
2nd Department of Cardiology, 2nd Chair of Cardiology, Medical University of Lodz, Poland
2
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
3
Department of Cardiology and Internal Diseases, Military Institute of Medicine, Warsaw, Poland
Submission date: 2025-09-30
Acceptance date: 2025-10-26
Online publication date: 2025-10-31
Corresponding author
Robert Morawiec
2nd Department of Cardiology 2nd Chair of Cardiology Medical University of Lodz, Poland
2nd Department of Cardiology 2nd Chair of Cardiology Medical University of Lodz, Poland
Arch Med Sci 2025;21(5):2179-2183
TOPICS
REFERENCES (15)
1.
Brouwers FP, de Boer RA, van der Harst P, et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 2013; 34: 1424-31.
2.
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2021; 42: 3599-726.
3.
Lelonek M, Gąsior M, Grabowski M. The HF-POL study – the first real-life multicenter study of Polish patients with heart failure and left ventricular ejection fraction >40%: study rationale and design. Kardiol Pol 2022; 80: 1145-7.
4.
Tomasoni D, Vitale C, Guidetti F, et al. The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: data from the Swedish Heart Failure Registry. Eur J Heart Fail 2024; 26: 854-68.
5.
Lund LH, Crespo-Leiro MG, Laroche C, et al. Heart failure in Europe: guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry. Eur J Heart Fail 2024; 26: 2487-501.
6.
Kapłon-Cieślicka A, Benson L, Chioncel O, et al. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC-HFA EORP Heart Failure Long-Term Registry. Eur J Heart Fail 2022; 24: 335-50.
7.
Drożdż J, Morawiec R, Drozd M, et al. Rationale, objectives and design of the HEart failuRe ObsErvational Study of the Polish Cardiac Society (HEROES). Kardiol Pol 2025; 83: 321-4.
8.
Koh AS, Tay WT, Teng THK, et al. A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail 2017; 19: 1624-34.
9.
Marai I, Andria N, Grosman-Rimon L, et al. Clinical and echocardiographic characteristics of patients with preserved versus mid-range ejection fraction. Int J Cardiovasc Imaging 2021; 37: 503-8.
10.
Chioncel O, Lainscak M, Seferovic PM, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 2017; 19: 1574-85.
11.
Rickenbacher P, Kaufmann BA, Maeder MT, et al. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Eur J Heart Fail 2017; 19: 1586-96.
12.
Major K, Sawościan M, Budnik M, et al. Baseline characteristics of Polish patients with heart failure with ejection fraction > 40%: results of HF-POL, the first study of the Heart Failure Association. Kardiol Pol 2024; 82: 427-30.
13.
Timmis A, Aboyans V, Vardas Pet al. European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics. Eur Heart J 2024; 45: 4019-62.
14.
Niewydolność serca w Polsce. Realia, koszty, sugestie poprawy sytuacji [Heart Failure in Poland: Realities, Costs, Suggestions for Improvement]. https://ptkardio.pl/wazne/rapo... Accessed: March 3, 2024. [on-line].
15.
Lindberg F, Benson L, Dahlström U, et al. Trends in heart failure mortality in Sweden between 1997 and 2022. Eur J Heart Fail 2025; 27: 366-76.
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
